Viewing Study NCT02996461

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:46 PM
Ignite Modification Date: 2026-02-23 @ 2:21 AM
Study NCT ID: NCT02996461
Status: COMPLETED
Last Update Posted: 2019-12-17
First Post: 2016-12-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: VRC 320: A Phase I, Randomized Clinical Trial to Evaluate the Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA090-00-VP, Administered Via Needle and Syringe or Needle-free Injector, PharmaJet, inHealthy Adults
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prevention of Zika Infection View
None Zika-Specific Immune Response View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Zika Infection View
None Immune Response View
None Flavivirus View
None Arthropod-Borne Virus View